Micro Emerging Active

ZLAB gains EMA orphan drug designation for DLL3-targeting cancer therapy

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Jul 01, 2026
Zai Lab Limited (ZLAB) Gains EMA Orphan Drug Designation for DLL3-Targeting Cancer … Neutral

Timeline

Last UpdatedJul 01, 2026